235 related articles for article (PubMed ID: 19798624)
41. [Retinopathy of Prematurity - Update on Classification, Screening, and Therapy].
Li JQ; Kellner U; Lorenz B; Stahl A; Krohne TU
Klin Monbl Augenheilkd; 2022 Mar; 239(3):346-363. PubMed ID: 35253129
[TBL] [Abstract][Full Text] [Related]
42. The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge.
Cavallaro G; Filippi L; Bagnoli P; La Marca G; Cristofori G; Raffaeli G; Padrini L; Araimo G; Fumagalli M; Groppo M; Dal Monte M; Osnaghi S; Fiorini P; Mosca F
Acta Ophthalmol; 2014 Feb; 92(1):2-20. PubMed ID: 23617889
[TBL] [Abstract][Full Text] [Related]
43. No advanced retinopathy of prematurity stages 4 or 5 in a large high-risk German cohort.
Muether PS; Kribs A; Hahn M; Schumacher J; Eifinger F; Kirchhof B; Roth B; Fauser S
Br J Ophthalmol; 2012 Mar; 96(3):400-4. PubMed ID: 21719567
[TBL] [Abstract][Full Text] [Related]
44. Bevacizumab for retinopathy of prematurity.
Gilbert CE; Zin A; Darlow B
N Engl J Med; 2011 Jun; 364(24):2359-60; author reply 2361-2. PubMed ID: 21675898
[No Abstract] [Full Text] [Related]
45. [Retinopathy of prematurity].
Jandeck C; Stahl A
Klin Monbl Augenheilkd; 2012 May; 229(5):559-75; quiz 576-7. PubMed ID: 22592347
[No Abstract] [Full Text] [Related]
46. Intravitreous bevacizumab as anti-vascular endothelial growth factor therapy for retinopathy of prematurity: a morphologic study.
Kong L; Mintz-Hittner HA; Penland RL; Kretzer FL; Chévez-Barrios P
Arch Ophthalmol; 2008 Aug; 126(8):1161-3. PubMed ID: 18695118
[No Abstract] [Full Text] [Related]
47. Retinopathy of prematurity.
Dobson V; Quinn GE
Optom Clin; 1996; 5(2):105-24. PubMed ID: 8837129
[TBL] [Abstract][Full Text] [Related]
48. Intravitreal bevacizumab as supplemental treatment or monotherapy for severe retinopathy of prematurity.
Axer-Siegel R; Snir M; Ron Y; Friling R; Sirota L; Weinberger D
Retina; 2011; 31(7):1239-47. PubMed ID: 21555969
[TBL] [Abstract][Full Text] [Related]
49. [Childhood retinal detachment: ROP and myopia].
Müller B; Joussen AM
Klin Monbl Augenheilkd; 2013 Sep; 230(9):894-901. PubMed ID: 23986188
[TBL] [Abstract][Full Text] [Related]
50. New insights in diagnosis and treatment for Retinopathy of Prematurity.
Cernichiaro-Espinosa LA; Olguin-Manriquez FJ; Henaine-Berra A; Garcia-Aguirre G; Quiroz-Mercado H; Martinez-Castellanos MA
Int Ophthalmol; 2016 Oct; 36(5):751-60. PubMed ID: 26767656
[TBL] [Abstract][Full Text] [Related]
51. Retinopathy of prematurity as a major cause of severe visual impairment and blindness in children in schools for the blind in Guadalajara city, Mexico.
Zepeda-Romero LC; Barrera-de-Leon JC; Camacho-Choza C; Gonzalez Bernal C; Camarena-Garcia E; Diaz-Alatorre C; Gutierrez-Padilla JA; Gilbert C
Br J Ophthalmol; 2011 Nov; 95(11):1502-5. PubMed ID: 21653214
[TBL] [Abstract][Full Text] [Related]
52. [Retinopathy of prematurity--pathogenesis and prevalence].
Modrzejewska M
Ann Acad Med Stetin; 2006; 52(1):67-72; discussion 72. PubMed ID: 17131849
[TBL] [Abstract][Full Text] [Related]
53. Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II.
Mintz-Hittner HA; Kuffel RR
Retina; 2008 Jun; 28(6):831-8. PubMed ID: 18536599
[TBL] [Abstract][Full Text] [Related]
54. Retinopathy of prematurity: two distinct mechanisms that underlie zone 1 and zone 2 disease.
Flynn JT; Chan-Ling T
Am J Ophthalmol; 2006 Jul; 142(1):46-59. PubMed ID: 16815250
[TBL] [Abstract][Full Text] [Related]
55. [Current ophthalmic aspects of acute retinopathy of prematurity].
Lorenz B
Ophthalmologe; 2008 Dec; 105(12):1092-100. PubMed ID: 19037646
[TBL] [Abstract][Full Text] [Related]
56. Retinopathy of prematurity.
Chen J; Smith LE
Angiogenesis; 2007; 10(2):133-40. PubMed ID: 17332988
[TBL] [Abstract][Full Text] [Related]
57. Bevacizumab for retinopathy of prematurity.
Reynolds JD
N Engl J Med; 2011 Feb; 364(7):677-8. PubMed ID: 21323546
[No Abstract] [Full Text] [Related]
58. [Screening for retinopathy of prematurity-the most important changes in the new German guidelines 2020].
Li JQ; Kellner U; Lorenz B; Stahl A; Krohne TU
Ophthalmologe; 2021 Dec; 118(12):1240-1244. PubMed ID: 33931789
[TBL] [Abstract][Full Text] [Related]
59. [Retinopathy of prematurity: screening and therapeutic indications].
Tălu S; Zaharia G; Vasile G
Oftalmologia; 2005; 49(1):12-6. PubMed ID: 15934330
[TBL] [Abstract][Full Text] [Related]
60. Systemic Solutions in Retinopathy of Prematurity.
Moshfeghi DM
Am J Ophthalmol; 2018 Sep; 193():xiv-xviii. PubMed ID: 29792838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
